Literature DB >> 15761015

Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation.

Wen-Chien Chou1, Hsuan-Yu Chen, Sung-Liang Yu, Linzhao Cheng, Pan-Chyr Yang, Chi V Dang.   

Abstract

The mechanism by which arsenic dramatically affects gene expression remains poorly understood. Here we report that prolonged exposure of acute promyelocytic leukemia NB4 cells to low levels of arsenic trioxide increased the expression of a set of genes responsible for reactive oxygen species (ROS) production. We hypothesize that arsenic-induced ROS in turn contribute partially to altered gene expression. To identify genes responsive to arsenic-induced ROS, we used microarray gene expression analysis and identified genes that responded to arsenic and hydrogen peroxide but whose response to arsenic was reversed by an ROS scavenger, N-acetyl-L-cysteine. We found that 26% of the genes significantly responsive to arsenic might have been directly altered by ROS. We further explored the mechanisms by which ROS affects gene regulation and found that the Sp1 transcription factor was oxidized by arsenic treatment, with a corresponding decrease in its in situ binding on the promoters of 3 genes, hTERT, C17, and c-Myc, whose expressions were significantly suppressed. We conclude that ROS contributed partly to arsenic-mediated gene regulation and that Sp1 oxidation contributed to gene suppression by arsenic-induced ROS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15761015      PMCID: PMC1895131          DOI: 10.1182/blood-2005-01-0241

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  46 in total

1.  2'-deoxyguanosine oxidation is associated with decrease in the DNA-binding activity of the transcription factor Sp1 in liver and kidney from diabetic and insulin-resistant rats.

Authors:  O Ramon; H K Wong; M Joyeux; J Riondel; S Halimi; J L Ravanat; A Favier; J Cadet; P Faure
Journal:  Free Radic Biol Med       Date:  2001-01-01       Impact factor: 7.376

2.  Negative regulatory role of Sp1 in metal responsive element-mediated transcriptional activation.

Authors:  Y Ogra; K Suzuki; P Gong; F Otsuka; S Koizumi
Journal:  J Biol Chem       Date:  2001-02-06       Impact factor: 5.157

3.  Identification of proteins containing cysteine residues that are sensitive to oxidation by hydrogen peroxide at neutral pH.

Authors:  J R Kim; H W Yoon; K S Kwon; S R Lee; S G Rhee
Journal:  Anal Biochem       Date:  2000-08-01       Impact factor: 3.365

4.  Roles of superoxide radical anion in signal transduction mediated by reversible regulation of protein-tyrosine phosphatase 1B.

Authors:  W C Barrett; J P DeGnore; Y F Keng; Z Y Zhang; M B Yim; P B Chock
Journal:  J Biol Chem       Date:  1999-12-03       Impact factor: 5.157

Review 5.  Oxidation of zinc finger transcription factors: physiological consequences.

Authors:  K A Webster; H Prentice; N H Bishopric
Journal:  Antioxid Redox Signal       Date:  2001-08       Impact factor: 8.401

6.  Neutrophil-specific granule deficiency: homozygous recessive inheritance of a frameshift mutation in the gene encoding transcription factor CCAAT/enhancer binding protein--epsilon.

Authors:  A F Gombart; M Shiohara; S H Kwok; K Agematsu; A Komiyama; H P Koeffler
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

7.  Substrates and products of eosinophil peroxidase.

Authors:  C J van Dalen; A J Kettle
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

8.  History of the development of arsenic derivatives in cancer therapy.

Authors:  S Waxman; K C Anderson
Journal:  Oncologist       Date:  2001

9.  Intraarticular release and accumulation of defensins and bactericidal/permeability-increasing protein in patients with rheumatoid arthritis.

Authors:  Maria I Bokarewa; Tao Jin; Andrej Tarkowski
Journal:  J Rheumatol       Date:  2003-08       Impact factor: 4.666

10.  Bromination of deoxycytidine by eosinophil peroxidase: a mechanism for mutagenesis by oxidative damage of nucleotide precursors.

Authors:  J P Henderson; J Byun; M V Williams; M L McCormick; W C Parks; L A Ridnour; J W Heinecke
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

View more
  22 in total

1.  Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth.

Authors:  Indira Jutooru; Gayathri Chadalapaka; Sandeep Sreevalsan; Ping Lei; Rola Barhoumi; Robert Burghardt; Stephen Safe
Journal:  Exp Cell Res       Date:  2010-05-08       Impact factor: 3.905

2.  Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation.

Authors:  Sabrina Copsel; Corina Garcia; Federico Diez; Monica Vermeulem; Alberto Baldi; Liliana G Bianciotti; Frans G M Russel; Carina Shayo; Carlos Davio
Journal:  J Biol Chem       Date:  2011-01-04       Impact factor: 5.157

3.  The Osteogenic Niche Is a Calcium Reservoir of Bone Micrometastases and Confers Unexpected Therapeutic Vulnerability.

Authors:  Hai Wang; Lin Tian; Jun Liu; Amit Goldstein; Igor Bado; Weijie Zhang; Benjamin R Arenkiel; Zonghai Li; Meng Yang; Shiyu Du; Hong Zhao; David R Rowley; Stephen T C Wong; Zbigniew Gugala; Xiang H-F Zhang
Journal:  Cancer Cell       Date:  2018-11-12       Impact factor: 31.743

Review 4.  The Dual Role of ROS in Hematological Malignancies: Stem Cell Protection and Cancer Cell Metastasis.

Authors:  Azin Samimi; Mohammad Javad Khodayar; Hadis Alidadi; Elahe Khodadi
Journal:  Stem Cell Rev Rep       Date:  2020-04       Impact factor: 5.739

Review 5.  From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia.

Authors:  Sai-Juan Chen; Guang-Biao Zhou; Xiao-Wei Zhang; Jian-Hua Mao; Hugues de Thé; Zhu Chen
Journal:  Blood       Date:  2011-03-21       Impact factor: 22.113

6.  Realgar nanoparticles versus ATO arsenic compounds induce in vitro and in vivo activity against multiple myeloma.

Authors:  Danka Cholujova; Zdenka Bujnakova; Erika Dutkova; Teru Hideshima; Richard W Groen; Constantine S Mitsiades; Paul G Richardson; David M Dorfman; Peter Balaz; Kenneth C Anderson; Jana Jakubikova
Journal:  Br J Haematol       Date:  2017-10-19       Impact factor: 6.998

7.  Characterization of arsenic-induced cytogenetic alterations in acute promyelocytic leukemia cell line, NB4.

Authors:  Marjan Yaghmaie; Hossein Mozdarani; Kamran Alimoghaddam; Seyed Hamidullah Ghaffari; Ardeshir Ghavamzadeh; Marjan Hajhashemi
Journal:  Med Oncol       Date:  2011-05-05       Impact factor: 3.064

8.  The control of reactive oxygen species production by SHP-1 in oligodendrocytes.

Authors:  Ross C Gruber; Daria LaRocca; Scott B Minchenberg; George P Christophi; Chad A Hudson; Alex K Ray; Bridget Shafit-Zagardo; Paul T Massa
Journal:  Glia       Date:  2015-04-27       Impact factor: 7.452

9.  Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration.

Authors:  Gang-Ming Zou; Anirban Maitra
Journal:  Mol Cancer Ther       Date:  2008-07       Impact factor: 6.261

10.  Post-translational control of sp-family transcription factors.

Authors:  J S Waby; C D Bingle; B M Corfe
Journal:  Curr Genomics       Date:  2008       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.